FDA Approved: VALSARTAN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for valsartan from Aurobindo Pharma Limited, allowing changes to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)